Rapid Mendelian Genes Sequencing Panel, Trio
Ordering Recommendation

Rapid diagnosis of a critically ill individual suspected to be affected with a Mendelian genetic condition. Parental samples are required to interpret the patient's result.

Massively Parallel Sequencing
2-4 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Lavender (EDTA). Peripheral blood required.
AND Maternal Specimen: Lavender (EDTA). Peripheral blood required.
AND Paternal Specimen: Lavender (EDTA). Peripheral blood required. 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
AND Maternal Specimen: Transport 3 mL whole blood. (Min: 1 mL)
AND Paternal Specimen: Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Unacceptable Conditions
Specimens from both parents must also be submitted for proper interpretation 
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
By report
Interpretive Data
Refer to report.

Compliance Statement C: For human genetic inheritable conditions and mutations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

The following must be submitted with the test order: Completed Rapid Sequencing consent form signed by a legal guardian and a completed Patient History for Rapid Sequencing form for each specimen. Control specimens from both parents must be submitted and a Genomics Control (ARUP Test Code 2007820) should be also ordered (at no additional charge) to aid in the interpretation of the patient's result. For each parental specimen, please indicate on the test requisition form that the specimen is either a "maternal control" or "paternal control" and clearly reference the patient's name.
Hotline History
View Hotline History
Component Test Code*Component Chart NameLOINC
2012850Rapid Sequencing Specimen
2012851Rapid Sequencing Interpretation
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Critical Care Sequencing Panel
  • Inherited Disease Sequencing Panel
  • Neonatal Crisis Sequencing Panel
  • NICU Sequencing Panel